What is the main purpose of this debt issuance?

The primary purpose of this $750 million debt issuance is to redeem and retire the company's outstanding $750 million of 3.00% notes due 2025. This allows CME Group to proactively manage its debt maturity profile and refinance maturing obligations.

How does this new debt issuance affect CME Group's financial leverage and interest expense?

The principal amount of debt remains the same ($750 million), but the interest rate has increased from 3.00% to 4.400%. This will result in higher annual interest expense, reflecting current market interest rates. The company's overall leverage may not significantly change if the new debt replaces the old debt dollar-for-dollar.

What are the key terms and investor protections in the new notes?

The notes are due in 2030 with a fixed coupon of 4.400%, payable semi-annually. The Indenture includes standard covenants that restrict the company's ability to incur certain liens or engage in major asset sales. Notably, a change of control event would trigger an offer to repurchase the notes at 101% of their principal amount, providing a layer of protection to investors.

When can the company redeem these new notes before maturity?

CME Group has the option to redeem the notes at any time. Prior to February 15, 2030 (one month before maturity), redemption will occur at the greater of 100% of the principal amount or a 'make-whole' amount, plus accrued interest. On or after February 15, 2030, the company can redeem the notes at 100% of the principal amount plus accrued interest.

CME 8-K: Material Agreements

Summary

CME Group Inc. has announced the successful completion of a $750 million public offering of 4.400% Notes due 2030. This offering was made under a previously filed shelf registration statement. The primary use of proceeds is to retire the outstanding $750 million of 3.00% notes due in 2025, effectively refinancing this debt at a higher coupon but extending the maturity. The remaining proceeds will be allocated to general corporate purposes. This move indicates a proactive approach by CME Group to manage its capital structure. By refinancing its 2025 notes, the company is extending its debt maturity profile. Investors should note the new notes carry a higher interest rate, reflecting current market conditions, but also provide more long-term funding. The indenture includes customary covenants and provisions for change of control, offering certain protections to noteholders.

Key Highlights

1Completed a $750 million public offering of 4.400% Notes due 2030.
2Net proceeds will be used to redeem $750 million of 3.00% notes due 2025.
3This transaction effectively refinances maturing debt with new, longer-term debt.
4The new notes carry a fixed interest rate of 4.400%, payable semi-annually.
5The offering was made under an automatic shelf registration statement.
6The Indenture includes covenants limiting liens, sale and leaseback transactions, and asset dispositions.
7A change of control triggering event requires the company to offer to repurchase notes at 101% of principal.

CME GROUP INC. 8-K Report, Material Agreement (Mar 10, 2025)

Summary

Key Highlights

Frequently Asked Questions